Novack; Aaron

Patent Applications and Registrations

Patent applications and USPTO patent grants for Novack; Aaron.The latest application filed is for "n-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides".

Company Profile

1.17.16

Novack; Aaron - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides Grant 9,409,909 - Charvat , et al. August 9, 2	2016-08-09
N-(2-(hetaryl)aryl)arylsulfonamides And N-(2-(hetaryl)hetaryl)arylsulfonamides App 20150018337 - Charvat; Trevor T. ; et al.	2015-01-15
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,846,675 - Ma , et al. September 30, 2	2014-09-30
N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides Grant 8,835,468 - Charvat , et al. September 16, 2	2014-09-16
Gpr120 Receptor Agonists And Uses Thereof App 20140121246 - Shi; Dong Fang ; et al.	2014-05-01
GPR120 receptor agonists and uses thereof Grant 8,598,374 - Shi , et al. December 3, 2	2013-12-03
Triazolyl phenyl benzenesulfonamides Grant 8,481,579 - Charvat , et al. July 9, 2	2013-07-09
GPR120 receptor agonists and uses thereof Grant 8,476,308 - Shi , et al. July 2, 2	2013-07-02
Gpr120 Receptor Agonists And Uses Thereof App 20130131351 - Shi; Dong Fang ; et al.	2013-05-23
Gpr120 Receptor Agonists And Uses Thereof App 20130109734 - Shi; Dong Fang ; et al.	2013-05-02
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20120322804 - Ma; Jingyuan ; et al.	2012-12-20
GPR120 receptor agonists and uses thereof Grant 8,309,600 - Shi , et al. November 13, 2	2012-11-13
GPR120 receptor agonists and uses thereof Grant 8,299,117 - Shi , et al. October 30, 2	2012-10-30
N-(2-(hetaryl)aryl)arylsulfonamides And N-(2-(hetaryl)hetaryl Arylsulfonamides App 20120245138 - Charvat; Trevor T. ; et al.	2012-09-27
Triazolyl Phenyl Benzenesulfonamides App 20120165303 - Charvat; Trevor T. ; et al.	2012-06-28
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides Grant 8,198,309 - Charvat , et al. June 12, 2	2012-06-12
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,183,381 - Ma , et al. May 22, 2	2012-05-22
Triazolyl phenyl benzenesulfonamides Grant 8,153,818 - Charvat , et al. April 10, 2	2012-04-10
Gpr120 Receptor Agonists And Uses Thereof App 20110313003 - Shi; Dong Fang ; et al.	2011-12-22
N-(2-(hetaryl)aryl) Arylsulfonamides And N-(2-(hetaryl)hetaryl Arylsulfonamides App 20100331302 - Charvat; Trevor T. ; et al.	2010-12-30
Aryl Gpr120 Receptor Agonists And Uses Thereof App 20100216827 - Ma; Jingyuan ; et al.	2010-08-26
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides Grant 7,776,877 - Charvat , et al. August 17, 2	2010-08-17
Gpr120 Receptor Agonists And Uses Thereof App 20100190831 - Shi; Dong Fang ; et al.	2010-07-29
Triazolyl Phenyl Benzenesulfonamides App 20100190762 - Charvat; Trevor T. ; et al.	2010-07-29
Triazolyl phenyl benzenesulfonamides Grant 7,718,683 - Charvat , et al. May 18, 2	2010-05-18
Substituted quinolones and methods of use Grant 7,557,213 - Melikian , et al. July 7, 2	2009-07-07
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090137590 - Ma; Jingyuan ; et al.	2009-05-28
N-(2-(hetaryl)aryl) Arylsulfonamides And N-(2-(hetaryl) Hetaryl Arylsulfonamides App 20090005410 - Charvat; Trevor T. ; et al.	2009-01-01
Triazolyl Phenyl Benzenesulfonamides App 20080039465 - Charvat; Trevor T. ; et al.	2008-02-14
Substituted quinolones and methods of use App 20070167443 - Melikian; Anita ; et al.	2007-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.